weight management options

GLP-1

GLP-1 agonists for weight loss

The FDA currently approves the use of GLP-1 agonists to help treat obesity. This is because these GLP-1 agonists have weight loss effects. Obesity is a chronic condition in which you have a body mass index (BMI) of 30 or higher.

Healthcare providers may also prescribe GLP-1’s for people who are overweight along with other health conditions if losing weight can help manage the coexisting conditions. Overweight is a BMI of 25 to 29.9

***Compounded medications 

Are NOT FDA-approved and are prescribed off-label based on individual medical need. Retatrutide is still in clinical trials.  We utilize compounding pharmacies from the Green List.

Injections weekly in office

·

Compounded Tirzepatide

·

·

Injections weekly in office · Compounded Tirzepatide · ·

Risks / Benefits

What are the potential benefits of GLP-1 agonists?

Other than lowering blood sugar levels and reducing weight, studies show that GLP-1 agonists may have other potential benefits, like:

What are the side effects of GLP-1 agonists?

The most common side effects of GLP-1 agonists include:

These side effects are more likely to happen when you start the medication or if you’re taking an increased dose.

Other side effects can include:

You may also have temporary mild itchiness and/or redness on your skin at the site of the injections.

Severe — but rare —

side effects can include:

Tirzepatide is a once-weekly injectable prescription medication that mimics two natural gut hormones (GIP and GLP-1) to improve blood sugar control and reduce appetite.

How It Works

  • Insulin regulation: Tells the pancreas to release more insulin when blood sugar levels are high.

  • Digestion slowdown: Delays how fast food leaves the stomach to help you feel full longer.

  • Appetite suppression: Acts on brain regions that control hunger and reduce food cravings.

    Side Effects & Risks

    • Mild to moderate: Nausea, vomiting, diarrhea, constipation, stomach pain, and decreased appetite.

    • Serious warnings: Risk of thyroid C-cell tumors (seen in animal studies); do not use if you have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

    • Other risks: Pancreatitis, gallbladder problems, or severe low blood sugar when combined with other diabetes drugs like insulin.